Published in Cochrane Database Syst Rev on July 06, 2011
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma. J Exp Clin Cancer Res (2014) 0.96
Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med (2012) 0.94
Obesity and reproductive function. Obstet Gynecol Clin North Am (2012) 0.91
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod (2014) 0.89
The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol (2014) 0.88
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril (2013) 0.82
Hyperinsulinaemic androgen excess in adolescent girls. Nat Rev Endocrinol (2014) 0.81
Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study. PLoS One (2015) 0.81
Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol (2012) 0.81
Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health (2014) 0.80
The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome. Diabetes Care (2012) 0.79
Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review. Adv Nutr (2014) 0.78
Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome. Obes Surg (2014) 0.78
Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]). Geburtshilfe Frauenheilkd (2015) 0.77
Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor. Int J Womens Health (2012) 0.75
Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome. Int J Endocrinol (2016) 0.75
Exercise prior to assisted fertilization in overweight and obese women (FertilEX): study protocol for a randomized controlled trial. Trials (2016) 0.75
Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries. Reprod Biol Endocrinol (2012) 0.75
Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Res Notes (2016) 0.75
Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome. Sci Rep (2016) 0.75
Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome. J Reprod Infertil (2016) 0.75
Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome. EBioMedicine (2017) 0.75
Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK. BMJ Open (2017) 0.75
Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo) (2015) 0.75
Ovarian reserve in women of late reproductive age by the method of treatment of PCOS. Iran J Reprod Med (2015) 0.75
Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment. Curr Psychiatry Rep (2017) 0.75
Endocrine evaluation of hirsutism. Int J Womens Dermatol (2017) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med (2008) 3.25
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ (2003) 2.40
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol (2011) 1.94
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2010) 1.86
Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem (2009) 1.82
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2013) 1.81
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause (2009) 1.55
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod (2013) 1.55
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
Power Doppler assessment of follicle vascularity at the time of oocyte retrieval in in vitro fertilization cycles. Fertil Steril (2008) 1.44
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology (2008) 1.41
Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. J Clin Endocrinol Metab (2009) 1.40
Macrophage contributions to ovarian function. Hum Reprod Update (2004) 1.35
Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development. Biol Reprod (2010) 1.34
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril (2008) 1.30
A systematic review of interventions aimed at the prevention of weight gain in adults. Public Health Nutr (2009) 1.30
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer. Fertil Steril (2006) 1.30
High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates. Endocrinology (2010) 1.29
The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.29
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust (2011) 1.23
Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring) (2009) 1.22
Measuring physical activity during pregnancy. Int J Behav Nutr Phys Act (2011) 1.22
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2010) 1.21
Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev (2010) 1.16
Programming and reproductive functioning. Trends Endocrinol Metab (2002) 1.14
Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril (2010) 1.12
Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet (2002) 1.11
Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab (2007) 1.10
Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril (2009) 1.08
Weight, physical activity and dietary behavior change in young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutr J (2009) 1.08
Impact of obesity on female fertility and fertility treatment. Womens Health (Lond Engl) (2008) 1.07
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2009) 1.06
Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.05
Knowledge about factors that influence fertility among Australians of reproductive age: a population-based survey. Fertil Steril (2012) 1.05
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update (2010) 1.03
Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod (2004) 1.02
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr (2006) 1.02
Single embryo transfer reduces the risk of perinatal mortality, a population study. Hum Reprod (2012) 1.01
The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) (2003) 0.99
Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes (2009) 0.99
Increased beta-oxidation and improved oocyte developmental competence in response to l-carnitine during ovarian in vitro follicle development in mice. Biol Reprod (2011) 0.98
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis (2008) 0.98
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril (2010) 0.98
C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.98
Preventing weight gain: the baseline weight related behaviors and delivery of a randomized controlled intervention in community based women. BMC Public Health (2009) 0.97
The longer-term health outcomes for children born as a result of IVF treatment. Part II--Mental health and development outcomes. Hum Reprod Update (2013) 0.97
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod (2009) 0.96
The longer-term health outcomes for children born as a result of IVF treatment: Part I--General health outcomes. Hum Reprod Update (2013) 0.95
Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol (2009) 0.95
Exposure to lipid-rich follicular fluid is associated with endoplasmic reticulum stress and impaired oocyte maturation in cumulus-oocyte complexes. Fertil Steril (2012) 0.94
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet (2013) 0.92
Infertility caused by HCG autoantibody. J Clin Endocrinol Metab (2002) 0.92
Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online (2006) 0.92
Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation. Biol Reprod (2002) 0.92
Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) (2010) 0.92
Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity (Silver Spring) (2013) 0.91
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) (2005) 0.91
The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) (2012) 0.91
Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt) (2015) 0.90
Endoplasmic reticulum (ER) stress in cumulus-oocyte complexes impairs pentraxin-3 secretion, mitochondrial membrane potential (DeltaPsi m), and embryo development. Mol Endocrinol (2012) 0.90
Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust (2012) 0.90
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr (2007) 0.89
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care (2008) 0.88
Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature. Aust N Z J Obstet Gynaecol (2004) 0.88
Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril (2011) 0.87
Soluble adhesion molecules in serum throughout the menstrual cycle. Hum Reprod (2002) 0.87
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Fertil Steril (2008) 0.86
The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab (2007) 0.86
Polycystic ovary syndrome - an update. Aust Fam Physician (2012) 0.86
The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.86
PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. PPAR Res (2008) 0.86
Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res (2007) 0.86
The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. Reprod Fertil Dev (2011) 0.86
Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med (2009) 0.85
Leptin and leptin receptor expression in the rat ovary. Endocrinology (2003) 0.85
Obesity and reproductive dysfunction in women. Endocrinol Metab Clin North Am (2011) 0.85
Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trial. BMC Public Health (2014) 0.85
Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health (2014) 0.85
Psychological effects of prescriptive vs general lifestyle advice for weight loss in young women. J Am Diet Assoc (2009) 0.85
The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol (2012) 0.84
Dietary effects on fertility treatment and pregnancy outcomes. Curr Opin Endocrinol Diabetes Obes (2007) 0.84